{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-26-030198","form_type":"8-K/A","ticker":"BLGO","cik":"0000880242","company_name":"BIOLARGO, INC.","filed_at":"2026-09-11T23:42:38+00:00","discovered_at":"2026-09-14T10:05:00.370364+00:00","generated_at":"2026-09-14T10:05:57.123758+00:00","sec_items":["7.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"low","headline":"BioLargo Q2 2026 earnings town hall held; figures not visible in filing excerpt","bullets":["BioLargo held Q2 2026 earnings call Sept 10, 2026 with CEO Dennis Calvert and CFO Charles Dargan.","No revenue, EPS, or guidance figures appear in the provided transcript excerpt; it cuts off at safe harbor language.","Investor relations contact Matt Kreps of Darrow Associates introduced the shareholder town hall.","Company addressed pre-submitted shareholder questions during the call; financial detail unavailable from this excerpt."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-030198","json":"https://secwatch.observer/filing/0001437749-26-030198.json","markdown":"https://secwatch.observer/filing/0001437749-26-030198.md","text":"https://secwatch.observer/filing/0001437749-26-030198.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/880242/000143774926030198/0001437749-26-030198-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/880242/000143774926030198/blgo20260911_8ka.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-14T10:05:57.123758+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}